Estradiol regulates GH-releasing peptide's interactions with GH-releasing hormone and somatostatin in postmenopausal women

Catalina Norman, Nanette L. Rollene, Dana Erickson, John MMiles, Cyril Y. Bowers, Johannes D. Veldhuis

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Objective: Estrogen stimulates pulsatile secretion of GH, via mechanisms that are largely unknown. An untested hypothesis is that estradiol (E 2) drives GH secretion by amplifying interactions among GH-releasing hormone (GHRH), somatostatin (SS), and GH-releasing peptide (GHRP). Design: The design comprised double-blind randomized prospective administration of transdermal E2 vs placebo to healthy postmenopausal women (n=24) followed by pulsatile GHRH or SS infusions for 13 h overnight with or without continuous GHRP2 stimulation. Methods: End points were mean concentrations, deconvolved secretion, and approximate entropy (ApEn; a regularity measure) of GH. Results: By generalized ANOVA models, it was observed that E2 vs placebo supplementation: i) augmented mean (13-h) GH concentrations (P=0.023), GHRH-induced pulsatile GH secretion over the first 3 h (P=0.0085) and pulsatile GH secretion over the next 10 h (P=0.054); ii) increased GHRP-modulated (P=0.022) and SS-modulated (P<0.001) GH ApEn; and iii) did not amplify GHRH/GHRP synergy during pulsatile GH secretion. By linear regression, E 2 concentrations were found to be positively correlated with GH secretion during GHRP2 infusion (P=0.022), whereas BMI was found to be negatively correlated with GH secretion during GHRH (P=0.006) and combined GHRH/GHRP (P=0.015) stimulation. E2 and BMI jointly determined triple (combined L-arginine, GHRH, and GHRP2) stimulation of GH secretion after saline (R2=0.44 and P=0.003) and pulsatile GHRH (R2=0.39 and P=0.013) infusions. Conclusion: In summary, in postmenopausal women, E 2 supplementation augments the amount (mass) and alters the pattern (regularity) of GH secretion via interactions among GHRH, SS, GHRP, and BMI. These outcomes introduce a more complex model of E2 supplementation in coordinating GH secretion in aging women.

Original languageEnglish (US)
Pages (from-to)121-129
Number of pages9
JournalEuropean journal of endocrinology
Issue number1
StatePublished - Jan 2014

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'Estradiol regulates GH-releasing peptide's interactions with GH-releasing hormone and somatostatin in postmenopausal women'. Together they form a unique fingerprint.

Cite this